Abstract：ObjectiveTo observe the clinical effect of treatment with Xingnaojing Injection on patients with severe craniocerebral injury.Methods90 patients with severe craniocerebral injury who were treated in our hospital from January 2016 to October 2017 were randomly divided into two groups according to random number table method.45 cases in the control group were treated by conventional therapy.45 cases in the study group were treated with Xingnaojing Injection，compared two groups of related clinical indicators data changes.ResultsThe Glasgow Coma Scale （GCS） score in the latter half month and one month after treatment in the study group was significantly higher than that in the control group，the difference was statistically significant（P＜0.05）.There was no significant difference in GCS score between three days and one week after treatment （P＞0.05）.The total effective rate and awake rate of clinical treatment in the study group were higher than those in the control group，the awake time was shorter than that in the control group，the incidence of complications and mortality were lower than the control group，the differences were statistically significant （P＜0.05）.ConclusionClinical treatment of patients with severe craniocerebral injury in the conventional treatment based on the use of Xingnaojing Injection for treatment，which can effectively control the patient′s condition，improve clinical outcomes and reduce the rate of adverse clinical reactions in patients with high safety，which will help shorten the patients Awake time to promote their physical recovery，it is worthy of clinical application.
关远志. 醒脑静注射液治疗重度颅脑损伤的临床效果观察[J]. 中国当代医药, 2018, 25(3): 51-53.
GUAN Yuan-zhi. Observe the clinical effect of Xingnaojing Injection in the treatment of severe craniocerebral injury. 中国当代医药, 2018, 25(3): 51-53.
京公网安备 11010502046607号